BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35916835)

  • 1. Epigallocatechin gallate as a nutraceutical to potentially target the metabolic syndrome: novel insights into therapeutic effects beyond its antioxidant and anti-inflammatory properties.
    Ntamo Y; Jack B; Ziqubu K; Mazibuko-Mbeje SE; Nkambule BB; Nyambuya TM; Mabhida SE; Hanser S; Orlando P; Tiano L; Dludla PV
    Crit Rev Food Sci Nutr; 2024; 64(1):87-109. PubMed ID: 35916835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates.
    James A; Wang K; Wang Y
    Nutrients; 2023 Jul; 15(13):. PubMed ID: 37447347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
    Nagle DG; Ferreira D; Zhou YD
    Phytochemistry; 2006 Sep; 67(17):1849-55. PubMed ID: 16876833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of EGCG: a patent review.
    Chakrawarti L; Agrawal R; Dang S; Gupta S; Gabrani R
    Expert Opin Ther Pat; 2016 Aug; 26(8):907-16. PubMed ID: 27338088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory Action of Green Tea.
    Ohishi T; Goto S; Monira P; Isemura M; Nakamura Y
    Antiinflamm Antiallergy Agents Med Chem; 2016; 15(2):74-90. PubMed ID: 27634207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
    Menegazzi M; Campagnari R; Bertoldi M; Crupi R; Di Paola R; Cuzzocrea S
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Green Tea (-)-Epigallocatechin-3-Gallate (EGCG) on Cardiac Function - A Review of the Therapeutic Mechanism and Potentials.
    Li Y; Karim MR; Wang B; Peng J
    Mini Rev Med Chem; 2022; 22(18):2371-2382. PubMed ID: 35345998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Epigallocatechin-3-gallate and hydroxytyrosol improved antioxidative and anti-inflammatory responses in bovine mammary epithelial cells.
    Basiricò L; Morera P; Dipasquale D; Bernini R; Santi L; Romani A; Lacetera N; Bernabucci U
    Animal; 2019 Dec; 13(12):2847-2856. PubMed ID: 31182175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate.
    Kim HS; Quon MJ; Kim JA
    Redox Biol; 2014; 2():187-95. PubMed ID: 24494192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells.
    Cavet ME; Harrington KL; Vollmer TR; Ward KW; Zhang JZ
    Mol Vis; 2011 Feb; 17():533-42. PubMed ID: 21364905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis.
    Mokra D; Joskova M; Mokry J
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
    Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
    Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tea-break with epigallocatechin gallate derivatives - Powerful polyphenols of great potential for medicine.
    Bakun P; Mlynarczyk DT; Koczorowski T; Cerbin-Koczorowska M; Piwowarczyk L; Kolasiński E; Stawny M; Kuźmińska J; Jelińska A; Goslinski T
    Eur J Med Chem; 2023 Dec; 261():115820. PubMed ID: 37776575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases.
    Eng QY; Thanikachalam PV; Ramamurthy S
    J Ethnopharmacol; 2018 Jan; 210():296-310. PubMed ID: 28864169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of green tea extract and epigallocatechin gallate in preventing bisphenol A-induced metabolic disorders in rats: Biochemical and molecular evidence.
    Mohsenzadeh MS; Razavi BM; Imenshahidi M; Tabatabaee Yazdi SA; Mohajeri SA; Hosseinzadeh H
    Phytomedicine; 2021 Nov; 92():153754. PubMed ID: 34607205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial.
    Brown AL; Lane J; Coverly J; Stocks J; Jackson S; Stephen A; Bluck L; Coward A; Hendrickx H
    Br J Nutr; 2009 Mar; 101(6):886-94. PubMed ID: 18710606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.
    Singh BN; Shankar S; Srivastava RK
    Biochem Pharmacol; 2011 Dec; 82(12):1807-21. PubMed ID: 21827739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cavernous antioxidant effect of green tea, epigallocatechin-3-gallate with/without sildenafil citrate intake in aged diabetic rats.
    Mostafa T; Sabry D; Abdelaal AM; Mostafa I; Taymour M
    Andrologia; 2013 Aug; 45(4):272-7. PubMed ID: 22928786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells.
    Kürbitz C; Heise D; Redmer T; Goumas F; Arlt A; Lemke J; Rimbach G; Kalthoff H; Trauzold A
    Cancer Sci; 2011 Apr; 102(4):728-34. PubMed ID: 21241417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.